MedTrace Logo

Enlighten Study: The EV-ICD Post Approval Registry

NCT06048731 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-07-30

No results posted yet for this study

Summary

Medtronic is sponsoring Enlighten: The EV-ICD Post Approval Registry, to further confirm safety and effectiveness of EV-ICD in routine clinical practice, following commercial release of EV-ICD devices.

Conditions

  • Ventricular Arrhythmia
  • Tachycardia

Interventions

DEVICE

Defibrillation using EV-ICD

Device: Defibrillation using the Extravascular ICD (EV-ICD)

Sponsors & Collaborators

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2030-05-31
Completion
2037-10-31

Countries

  • United States
  • Austria
  • Belgium
  • Canada
  • Czechia
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Hong Kong
  • Hungary
  • Israel
  • Italy
  • Kuwait
  • Netherlands
  • New Zealand
  • Poland
  • Portugal
  • Saudi Arabia
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06048731 on ClinicalTrials.gov